Conjupro Biotherapeutics, Inc.
Clinical trials sponsored by Conjupro Biotherapeutics, Inc., explained in plain language.
-
New weapon against advanced cancer begins human testing
Disease control Recruiting nowThis is a first-in-human study to test a new investigational drug called SYS6043 in adults with advanced or metastatic solid tumors that have spread or no longer respond to standard therapies. The main goals are to find a safe dose, understand the drug's side effects, and see how…
Phase: PHASE1 • Sponsor: Conjupro Biotherapeutics, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
New weapon against advanced cancer begins human testing
Disease control Recruiting nowThis is a first-in-human study to test the safety and find the right dose of a new experimental drug called CPO301 in adults with advanced or metastatic solid tumors that have stopped responding to standard treatments. The drug is designed to target and deliver a toxic payload sp…
Phase: PHASE1 • Sponsor: Conjupro Biotherapeutics, Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New cancer drug enters first human trials
Disease control Recruiting nowThis is an early-stage study testing a new drug called JMT108 in adults with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and see if the drug shows any early signs of helping to shrink tumors. Participants will recei…
Phase: PHASE1 • Sponsor: Conjupro Biotherapeutics, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC